


Mercator Announces Enrollment of First Patient in DEXTERITY-AFP Clinical Trial Treating Inflammation in Deep Vein Thrombosis
EMERYVILLE, Calif., November 3, 2021 – Mercator MedSystems, Inc. (“Mercator”), a medical technology company specializing in localized drug therapy, today announced enrollment of the first patient in the DEXTERITY (DEXamethasone Therapy Examining Reduction of...
Updates and Conferences
Mercator Medsystems featured in BTIG’s Analyst Report: Medical Technology and Digital Health: Highlighting Private Companies Across the Medical Technology and Digital Health Landscape – Vol 18. March 2022 LINC 2022 – June 6 – June 9, 2022 Past Events American...